FIELD: medical devices.
SUBSTANCE: group of inventions relates to medicinal product delivery through expandable catheters. The following is presented: a catheter comprising an expandable part on an elongated body; and a coating on the outer surface of the expandable part. The said coating contains a lipophilic matrix with at least one lipid, more than one microreservoir, including only a crystalline active agent dispersed in the lipophilic matrix. The lipophilic matrix is configured to adhere to the intraluminal surface when the expandable portion is inflated and transfer at least a part from more than one microreservoir to the intraluminal surface. More than one microreservoir is uniform in size and has a maximum particle size of 10 μm, and less than 5% of the more than one microreservoir has a diameter of 1 μm or less. A method of coating an expandable part of a catheter and a method of treating a condition at a treatment site are also described.
EFFECT: maximum therapeutic effect is achieved with minimal toxicity of high doses of medicinal products.
45 cl, 8 dwg, 20 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
COATING FOR AN INTRALUMINAL DIVERGENT CATHETER, PROVIDING CONTACT DELIVERY OF MICRORESERVOIRS WITH A DRUG PREPARATION | 2015 |
|
RU2721655C2 |
OXIDISED LIPIDES AND USE THEREOF FOR TREATING INFLAMMATORY DISEASES AND DISORDERS | 2009 |
|
RU2482854C2 |
PEGYLATED LIPID NANOPARTICLE WITH A BIOACTIVE LIPOPHILIC COMPOUND | 2016 |
|
RU2737893C2 |
OXIDISED LIPIDS AND THEIR APPLICATION FOR TREATMENT OF INFLAMMATORY DISEASES AND DISTURBANCES | 2004 |
|
RU2362567C2 |
RESPIRATORY INTRODUCTION OF TISSUE FACTOR PATHWAY INHIBITOR IN INFLAMMATORY CONDITIONS INVOLVING RESPIRATORY TRACT | 2006 |
|
RU2496516C2 |
STABILIZING PHARMACEUTICAL COMPOSITIONS OF CAMPTOTHECIN | 2016 |
|
RU2833053C2 |
PEPTIDE POSSESSING ABILITY TO RELIEVE AT LEAST ONE SYMPTOM OF INFLAMMATORY CONDITION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND METHOD OF TREATING ATHEROSCLEROSIS WITH THEIR APPLICATION | 2005 |
|
RU2448977C2 |
STABILIZED PHARMACEUTICAL COMPOSITIONS OF CAMPTOTHECIN | 2016 |
|
RU2732567C2 |
OXIDISED LIPID COMPOUNDS AND THEIR APPLICATION | 2009 |
|
RU2532546C2 |
COMPOSITIONS AND METHODS OF TREATING BLADDER CANCER | 2008 |
|
RU2542449C2 |
Authors
Dates
2024-06-10—Published
2019-10-14—Filed